Michael J Silverberg

Summary

Affiliation: Kaiser Permanente
Country: USA

Publications

  1. pmc HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer
    Michael J Silverberg
    Kaiser Permanente, Division of Research, 2000 Broadway, Oakland, CA 94612, USA
    J Natl Cancer Inst 105:350-60. 2013
  2. pmc Prescription long-term opioid use in HIV-infected patients
    Michael J Silverberg
    Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Clin J Pain 28:39-46. 2012
  3. pmc Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America
    Michael J Silverberg
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Clin Infect Dis 54:1026-34. 2012
  4. ncbi request reprint AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era
    Michael J Silverberg
    Division of Research, Kaiser Permanente Northern California, Oakland 94612, USA
    Curr Opin Oncol 19:446-51. 2007
  5. ncbi request reprint Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection
    Michael J Silverberg
    Kaiser Permanente Northern California, Oakland, California, USA
    Ann Intern Med 150:301-13. 2009
  6. pmc Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy
    Michael J Silverberg
    Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, USA
    J Pain Symptom Manage 38:197-207. 2009
  7. ncbi request reprint Effectiveness of highly-active antiretroviral therapy by race/ethnicity
    Michael J Silverberg
    Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA
    AIDS 20:1531-8. 2006
  8. pmc Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?
    Michael J Silverberg
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Curr Opin HIV AIDS 4:42-51. 2009
  9. pmc HIV infection, immunodeficiency, viral replication, and the risk of cancer
    Michael J Silverberg
    Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Cancer Epidemiol Biomarkers Prev 20:2551-9. 2011
  10. pmc Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care
    Michael J Silverberg
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    J Gen Intern Med 24:1065-72. 2009

Research Grants

Detail Information

Publications44

  1. pmc HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer
    Michael J Silverberg
    Kaiser Permanente, Division of Research, 2000 Broadway, Oakland, CA 94612, USA
    J Natl Cancer Inst 105:350-60. 2013
    ..001). Adjustment for number of outpatient visits did not affect the results. Conclusion HIV(+) subjects had a twofold higher incidence rate of NMSCs compared with HIV(-) subjects. SCCs but not BCCs were associated with immunodeficiency...
  2. pmc Prescription long-term opioid use in HIV-infected patients
    Michael J Silverberg
    Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Clin J Pain 28:39-46. 2012
    ..To examine changes the in use of prescription opioids for the management of chronic noncancer pain in human immunodeficiency virus (HIV)-infected patients and to identify patient characteristics associated with long-term use...
  3. pmc Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America
    Michael J Silverberg
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Clin Infect Dis 54:1026-34. 2012
    ..There are also conflicting data regarding calendar trends...
  4. ncbi request reprint AIDS-defining and non-AIDS-defining malignancies: cancer occurrence in the antiretroviral therapy era
    Michael J Silverberg
    Division of Research, Kaiser Permanente Northern California, Oakland 94612, USA
    Curr Opin Oncol 19:446-51. 2007
    ..Effective antiretroviral therapy use has resulted in a large number of older individuals living with HIV. Recent literature is reviewed with respect to the incidence and risk factors for cancer in HIV patients...
  5. ncbi request reprint Response to newly prescribed lipid-lowering therapy in patients with and without HIV infection
    Michael J Silverberg
    Kaiser Permanente Northern California, Oakland, California, USA
    Ann Intern Med 150:301-13. 2009
    ..Antiretroviral agents, particularly protease inhibitors (PIs), may adversely affect lipid levels in patients with HIV infection. However, it is not known whether HIV-associated dyslipidemia is more difficult to treat...
  6. pmc Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy
    Michael J Silverberg
    Department of Epidemiology, Johns Hopkins University, Baltimore, Maryland, USA
    J Pain Symptom Manage 38:197-207. 2009
    ..Clinicians should consider these factors when counseling patients regarding potential adverse effects of antiretrovirals or symptoms associated with HIV disease...
  7. ncbi request reprint Effectiveness of highly-active antiretroviral therapy by race/ethnicity
    Michael J Silverberg
    Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA
    AIDS 20:1531-8. 2006
    ..To determine the effectiveness of HAART by race/ethnicity...
  8. pmc Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?
    Michael J Silverberg
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Curr Opin HIV AIDS 4:42-51. 2009
    ..There is an increasing burden of non-AIDS-defining malignancies (NADMs) in the antiretroviral therapy (ART) era. The recent literature is reviewed with respect to NADM risk, ART use, and immune function...
  9. pmc HIV infection, immunodeficiency, viral replication, and the risk of cancer
    Michael J Silverberg
    Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Cancer Epidemiol Biomarkers Prev 20:2551-9. 2011
    ..Few studies have compared cancer risk between HIV-infected individuals and a demographically similar HIV-uninfected internal comparison group, adjusting for cancer risk factors...
  10. pmc Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care
    Michael J Silverberg
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    J Gen Intern Med 24:1065-72. 2009
    ..Prior studies evaluating racial/ethnic differences in responses to antiretroviral therapy (ART) among HIV-infected patients have not adequately accounted for many potential confounders, and few have included Hispanic patients...
  11. pmc HIV infection and the risk of cancers with and without a known infectious cause
    Michael J Silverberg
    Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612, USA
    AIDS 23:2337-45. 2009
    ..To evaluate the risk of cancers with and without a known infectious cause in HIV-infected persons...
  12. ncbi request reprint Older age and the response to and tolerability of antiretroviral therapy
    Michael J Silverberg
    Division of Research, Kaiser Permanente Northern California, 2000 Broadway, Oakland, CA 94612, USA
    Arch Intern Med 167:684-91. 2007
    ..The unique health needs of a growing older adult population infected with human immunodeficiency virus (HIV) require study, especially in terms of the response to and tolerability of highly active antiretroviral therapy (HAART)...
  13. pmc Prevalence of clinical symptoms associated with highly active antiretroviral therapy in the Women's Interagency HIV Study
    Michael J Silverberg
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA
    Clin Infect Dis 39:717-24. 2004
    ..The extended use of antiretroviral drugs among human immunodeficiency virus (HIV)-seropositive individuals underscores the need for a comprehensive evaluation of therapy-associated clinical symptoms...
  14. pmc Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women
    Michael J Silverberg
    Department of Epidemiology, Johns Hopkins University, Bloomberg School of Public Health, Baltimore, Maryland, USA
    Clin Vaccine Immunol 13:511-9. 2006
    ..Rises among HIV-positive women may more often result from reactivation of a latent HPV infection in the context of HIV-induced immunosuppression, while rises among HIV-negative women may more often result from reinfection with HPV...
  15. doi request reprint Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care
    Michael J Silverberg
    Division of Research, Kaiser Permanente Northern California, Oakland, CA Department of Research and Evaluation, Kaiser Permanente South California, Pasadena, CA Mid Atlantic Permanente Research Institute, Kaiser Permanente Mid Atlantic States, Rockville, MD Division of Infectious Diseases, Department of Internal Medicine, Kaiser Permanente Southern California, Los Angeles, CA and Division of Infectious Diseases, Kaiser Permanente Northern California, Hayward, CA
    J Acquir Immune Defic Syndr 65:160-6. 2014
    ..We sought to clarify the association of HIV infection and immunodeficiency on myocardial infarction (MI) risk...
  16. pmc The effect of HIV infection, immunodeficiency, and antiretroviral therapy on the risk of hepatic dysfunction
    William J Towner
    Department of Internal Medicine, Division of Infectious Diseases, Kaiser Permanente, Los Angeles, CA 90027, USA
    J Acquir Immune Defic Syndr 60:321-7. 2012
    ..Limited data exists regarding the effect of chronic HIV infection on the liver. We sought to characterize the hepatic risks of HIV infection, immunodeficiency, and cumulative use of antiretroviral therapy (ART)...
  17. pmc Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009
    David B Hanna
    Johns Hopkins University, Baltimore, Maryland, United States of America Albert Einstein College of Medicine, Bronx, New York, United States of America
    PLoS ONE 8:e78952. 2013
    ..States differ regarding their financial contributions to and ways of implementing these programs, and it remains unclear how this interstate variability affects HIV treatment outcomes...
  18. pmc Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009
    David B Hanna
    Johns Hopkins University, Baltimore, Maryland, USA
    Clin Infect Dis 56:1174-82. 2013
    ..We sought to examine trends in treatment initiation and resulting human immunodeficiency virus (HIV) virologic suppression in North America between 2001 and 2009, and demographic and geographic disparities in these outcomes...
  19. doi request reprint The epidemiology of herpes zoster in patients with newly diagnosed cancer
    Laurel A Habel
    Division of Research, Kaiser Permanente, Northern California, Oakland, CA, USA
    Cancer Epidemiol Biomarkers Prev 22:82-90. 2013
    ..Given the limited literature, we conducted a study to examine the epidemiology of herpes zoster (HZ) among newly diagnosed cancer patients...
  20. ncbi request reprint Risk of cancers during interrupted antiretroviral therapy in the SMART study
    Michael J Silverberg
    Division of Research, Kaiser Permanente Northern California, Oakland, California 94110, USA
    AIDS 21:1957-63. 2007
    ..To compare rates of AIDS-defining and non-AIDS-defining malignancies between patients on a CD4 T-cell-guided antiretroviral therapy (ART) strategy and continuous ART...
  21. pmc Age and gender trends in long-term opioid analgesic use for noncancer pain
    Cynthia I Campbell
    Division of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA
    Am J Public Health 100:2541-7. 2010
    ..We describe age and gender trends in long-term use of prescribed opioids for chronic noncancer pain in 2 large health plans...
  22. pmc Virologic and immunologic response to HAART, by age and regimen class
    Keri N Althoff
    Johns Hopkins University, Baltimore, Maryland 21287, USA
    AIDS 24:2469-79. 2010
    ..To determine the impact of age and initial HAART regimen class on virologic and immunologic response within 24 months after initiation...
  23. ncbi request reprint Clinical course of recurrent respiratory papillomatosis in Danish children
    Michael J Silverberg
    Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA
    Arch Otolaryngol Head Neck Surg 130:711-6. 2004
    ..To evaluate the clinical course of juvenile-onset recurrent respiratory papillomatosis (RP) with respect to age, disease duration, and maternal condylomas...
  24. pmc Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals
    Gregory M Lucas
    Johns Hopkins University, Baltimore, Maryland
    J Infect Dis 208:1240-9. 2013
    ..The role of active hepatitis C virus (HCV) replication in chronic kidney disease (CKD) risk has not been clarified...
  25. pmc Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study
    Alison G Abraham
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY Division of Infectious Diseases, School of Medicine, Vanderbilt University, Nashville, TN Division of Research, Kaiser Permanente Northern California, Oakland, CA Division of Infectious Diseases, University of Alabama, Birmingham, AL Ontario Treatment Network, University of Toronto, Toronto, ON, Canada Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC Department of Medicine, Johns Hopkins University, Baltimore, MD Department of Medicine, Division of Infectious Diseases Chronic Viral Illness Service, McGill University, Montreal, Quebec, Canada Department of Medicine, University of Washington, Seattle, WA Department of Health Sciences, British Columbia Centre for Excellence and HIV AIDS, Simon Fraser University, Vancouver, British Columbia, Canada Department of Clinical Pharmacy and Medicine, University of California, San Francisco, CA Infections and Immunoepidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD Department of Medicine, University of Calgary, Calgary
    J Acquir Immune Defic Syndr 62:405-13. 2013
    ..Few reported prospective cohort studies have characterized the incidence of invasive cervical cancer (ICC) in HIV-infected women...
  26. doi request reprint Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons
    Chun Chao
    Kaiser Permanente Southern California, Pasadena, CA, USA
    AIDS 26:2223-31. 2012
    ..Studies are needed to directly evaluate the effect of ART use on cancer risk...
  27. pmc CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?
    Keri N Althoff
    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD, 21205, USA
    AIDS Res Ther 7:45. 2010
    ..10%, respectively). Due to the increasing proportion, consistently lower CD4 counts, and more advanced HIV disease in adults ≥50-year-old at first presentation for HIV care, renewed HIV testing efforts are needed...
  28. pmc Retention among North American HIV-infected persons in clinical care, 2000-2008
    Peter Rebeiro
    Department of Epidemiology, Johns Hopkins University, Baltimore, MD, USA
    J Acquir Immune Defic Syndr 62:356-62. 2013
    ..Retention in care is key to improving HIV outcomes. The goal of this study was to describe 'churn' in patterns of entry, exit, and retention in HIV care in the United States and Canada...
  29. ncbi request reprint The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts
    Michael J Silverberg
    Johns Hopkins School of Public Health, Baltimore, Maryland 21205, USA
    Sex Transm Dis 29:427-35. 2002
    ..HIV infection and associated immunodeficiency are known to alter the course of human papillomavirus (HPV) infections and of associated diseases...
  30. pmc Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence
    Michael A Horberg
    Mid Atlantic Permanente Research Institute, Rockville, MD 20852, USA
    J Acquir Immune Defic Syndr 60:183-90. 2012
    ..We seek to determine the optimized multidisciplinary care team (MDCT) composition for antiretroviral therapy (ART) adherence...
  31. pmc Late presentation for human immunodeficiency virus care in the United States and Canada
    Keri N Althoff
    Johns Hopkins University, Baltimore, Maryland, USA
    Clin Infect Dis 50:1512-20. 2010
    ..CONCLUSION. CD4 count at first presentation for HIV care has increased annually over the past 11 years but has remained <350 cells/mm(3), which suggests the urgent need for earlier HIV diagnosis and treatment...
  32. doi request reprint Syphilis epidemiology and clinical outcomes in HIV-infected and HIV-uninfected patients in Kaiser Permanente Northern California
    Michael A Horberg
    Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA
    Sex Transm Dis 37:53-8. 2010
    ..We describe differences between HIV-infected and HIV-uninfected patients diagnosed with syphilis within Kaiser Permanente Northern California...
  33. doi request reprint Disparities in the Quality of HIV Care When Using US Department of Health and Human Services Indicators
    Keri N Althoff
    Johns Hopkins University, Baltimore, Maryland
    Clin Infect Dis 58:1185-9. 2014
    ..Interventions are needed to reduce retention- and treatment-related disparities. ..
  34. pmc Smoking enhances risk for new external genital warts in men
    Dorothy J Wiley
    Division of Primary Care, School of Nursing, University of California at Los Angeles UCLA, Los Angeles, California, USA
    Int J Environ Res Public Health 6:1215-34. 2009
    ..Multivariate analyses showed smoking, prior episodes of EGWs, HIV infection and CD4+ T-lymphocyte count among the infected, each differentially influenced the risk for new EGWs...
  35. pmc Trends in prescribed opioid therapy for non-cancer pain for individuals with prior substance use disorders
    Constance M Weisner
    Department of Psychiatry, University of California, San Francisco, CA 94143, USA
    Pain 145:287-93. 2009
    ....
  36. ncbi request reprint Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis
    Michael J Silverberg
    Department of Epidemiology, Baltimore, Maryland 21205 2179, USA
    Obstet Gynecol 101:645-52. 2003
    ....
  37. doi request reprint Factors contributing to risk for cancer among HIV-infected individuals, and evidence that earlier combination antiretroviral therapy will alter this risk
    Alvaro H Borges
    aDepartment of Infectious Diseases, Rigshospitalet and Copenhagen HIV Programme, University of Copenhagen, Faculty of Health Sciences, Copenhagen, Denmark bDepartment of Chronic Disease Epidemiology, Yale School of Public Health, Yale School of Medicine, New Haven, Connecticut cDivision of Research, Kaiser Permanente, Oakland, California, USA
    Curr Opin HIV AIDS 9:34-40. 2014
    ....
  38. ncbi request reprint Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus
    L Stewart Massad
    Southern Illinois University School of Medicine, Springfield, Illinois 62794 9640, USA
    Am J Obstet Gynecol 190:1241-8. 2004
    ..The purpose of this study was to determine the incidence and predictors of genital warts and vulvar intraepithelial neoplasia among women with the human immunodeficiency virus...
  39. ncbi request reprint Prospective study of attitudinal and relationship predictors of sexual risk in the multicenter AIDS cohort study
    David G Ostrow
    David Ostrow and Associates, Chicago MACS Howard Brown Health Center and Northwestern University School of Medicine, 5455 N Sheridan Rd, Suite 1207, Chicago, IL 60640, USA
    AIDS Behav 12:127-38. 2008
    ..We conclude that HIV prevention efforts should target modifiable attitudes (reduced concern about HIV and safer sex fatigue) and increases in sexual risk-taking of MSM, particularly among HIV+ men having sex with serodiscordant partners...
  40. ncbi request reprint Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results
    Tiffany G Harris
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    JAMA 293:1471-6. 2005
    ....
  41. pmc CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection
    Jason V Baker
    University of Minnesota, Minneapolis, USA
    AIDS 22:841-8. 2008
    ..Reductions in AIDS-related morbidity and mortality following the advent of combination antiretroviral therapy have coincided with relative increases in chronic non-AIDS end-organ diseases among HIV+ patients...
  42. ncbi request reprint Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women
    Howard D Strickler
    Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Ave, Belfer 1308, Bronx, NY 10461, USA
    J Natl Cancer Inst 97:577-86. 2005
    ....
  43. ncbi request reprint How condom use, number of receptive anal intercourse partners and history of external genital warts predict risk for external anal warts
    D J Wiley
    Division of Primary Care, School of Nursing, UCLA, Los Angeles, CA 90095 6919, USA
    Int J STD AIDS 16:203-11. 2005
    ....
  44. ncbi request reprint Timing and completeness of routine testing for antibodies to human immunodeficiency virus type 1 among active duty members of the U.S. Armed Forces
    Michael J Silverberg
    Army Medical Surveillance Activity, Walter Reed Army Medical Center, Washington, DC 20307, USA
    Mil Med 168:160-4. 2003
    ..The results of this analysis may inform the planning and conduct of human immunodeficiency virus type 1 prevention programs as well as deployment-related or other surveillance activities...

Research Grants2

  1. HIV Infection, Antiretroviral Therapy, Cancer Incidence and Progression
    Michael Silverberg; Fiscal Year: 2007
    ..The results of this research may be informative to those providing care to HIV-infected patients with or at-risk for cancer. ..